Cell Biology International · 2009 · 23 citations · 17 references
Life SciencesCell BiologyOncologyApoptosisCell SignalingMolecular OncologyApoptosis In CancerApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsCaspase ActivationCell-cycle DysregulationAnti-apoptotic ProteinsAntiapoptotic Protein RegulationAntiapoptotic Protein SignalingAnticancer ActivityApoptotic Signaling In CancerCancer Cell ApoptosisCdk InhibitorsM Phase Arrest
Calotropin is one of cardenolides isolated from milkweed used for medicinal purposes in many Asian countries. Whereas calotropin possesses cytotoxicity against several cancer cells, the mechanisms of action remain unclear. We set out to evaluate the cytotoxic mechanism of calotropin on human chronic myeloid leukemia K562 cells. Calotropin inhibited the growth of K562 cells in a time- and dose-dependent manner by G(2)/M phase arrest. It upregulated the expression of p27 leading to this arrest by downregulating the G2/M regulatory proteins, cyclins A and B, and by upregulating the cdk inhibitor, p27. Furthermore, it downregulated anti-apoptotic signaling (XIAP and survivin) and survival pathways (p-Akt and NFkappaB), leading to caspase-3 activation which resulted in the induction of apoptosis. In all, calotropin exerted its anticancer activity on K562 cells by modulating the pro-survival signaling that leads to induction of apoptosis.
17
Requirement for p53 and p21 to Sustain G <sub>2</sub> Arrest After DNA Damage
Fred Bunz, Annie Dutriaux, Christoph Lengauer et al. · Science · 1998 · 2.8K citations
Is a p53-Regulated Inhibitor of G2/M Progression
Heiko Hermeking, Christoph Lengauer, Kornélia Polyák et al. · Molecular Cell · 1997 · 1.2K citations · Full text
The Pezcoller lecture: cancer cell cycles revisited.